Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 44 Enz. Inhib. hit(s) with all data for entry = 8321
TargetGenome polyprotein [2420-3010,S282T](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240845(US9394331, 140 | US9394331, 52)
Affinity DataIC50:  5.67E+4nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010,S282T](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240843(US9394331, 137 | US9394331, 49)
Affinity DataIC50: >1.00E+5nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010,S282T](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240844(US9394331, 136 | US9394331, 48)
Affinity DataIC50: >1.00E+5nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240842(US9394331, 44)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240843(US9394331, 137 | US9394331, 49)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240844(US9394331, 136 | US9394331, 48)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240845(US9394331, 140 | US9394331, 52)
Affinity DataEC50: >5.45E+4nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240846(US9394331, 62)
Affinity DataEC50: >2.00E+4nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240847(US9394331, 72)
Affinity DataEC50: >2.00E+4nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240848(US9394331, 76)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240849(US9394331, 77)
Affinity DataEC50: >2.00E+4nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240850(US9394331, 66)
Affinity DataEC50: >2.00E+4nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240851(US9394331, 114)
Affinity DataEC50:  2.06E+4nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240852(US9394331, 115)
Affinity DataEC50:  2.85E+4nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240853(US9394331, 116)
Affinity DataEC50:  2.83E+4nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240854(US9394331, 117)
Affinity DataEC50:  1.67E+4nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240855(US9394331, 113)
Affinity DataEC50:  1.55E+3nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240856(US9394331, 118 | US9394331, 119)
Affinity DataEC50:  1.49E+3nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240856(US9394331, 118 | US9394331, 119)
Affinity DataEC50:  4.52E+3nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240858(US9394331, 120 | US9394331, 121)
Affinity DataEC50:  390nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240858(US9394331, 120 | US9394331, 121)
Affinity DataEC50:  9.31E+3nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240860(US9394331, 122)
Affinity DataEC50:  857nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240861(US9394331, 123)
Affinity DataEC50:  310nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240862(US9394331, 124)
Affinity DataEC50:  566nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240863(US9394331, 125)
Affinity DataEC50:  4.42E+3nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240864(US9394331, 126 | US9394331, 127)
Affinity DataEC50:  274nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240864(US9394331, 126 | US9394331, 127)
Affinity DataEC50:  3.10E+3nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240866(US9394331, 128 | US9394331, 129)
Affinity DataEC50:  450nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240866(US9394331, 128 | US9394331, 129)
Affinity DataEC50:  670nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240868(US9394331, 130 | US9394331, 131)
Affinity DataEC50:  8.65E+3nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240868(US9394331, 130 | US9394331, 131)
Affinity DataEC50:  1.17E+4nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240870(US9394331, 132)
Affinity DataEC50: >2.00E+4nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240871(US9394331, 133)
Affinity DataEC50: >2.00E+4nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240872(US9394331, 134)
Affinity DataEC50:  1.40E+4nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240838(US9394331, 135 | US9394331, 32)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240844(US9394331, 136 | US9394331, 48)
Affinity DataEC50:  3.94E+4nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240843(US9394331, 137 | US9394331, 49)
Affinity DataEC50: >4.53E+4nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240839(US9394331, 138 | US9394331, 50)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240841(US9394331, 139 | US9394331, 51)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240845(US9394331, 140 | US9394331, 52)
Affinity DataEC50: >8.48E+3nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240841(US9394331, 139 | US9394331, 51)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240840(US9394331, 36)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240838(US9394331, 135 | US9394331, 32)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetGenome polyprotein [2420-3010](HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM240839(US9394331, 138 | US9394331, 50)
Affinity DataEC50: >1.00E+5nMpH: 7.5 T: 27°CAssay Description:The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent